22 TWENTYFOURSEVENBIOPHARMA Issue 1 / March 2025 DCAT SUMMIT How is innovation inspiring and fueling the transformation of the biopharma industry? DCAT’s conference and networking event, Expedition Pharma: Innovation from a Patient-First Perspective, being held June 4–5, 2025, in Lugano, Switzerland, will provide key insights. DCAT’s European conference and networking event In 2024, the Drug, Chemical & Associated Technologies Association (DCAT) achieved a significant milestone in its 134-year history by hosting its first education and networking event outside the US. Responding to the needs of its diverse membership—over half of whom are headquartered outside the US—the Summit at Lugano brought together global thought leaders across all disciplines to address the topic of sustainability. This inaugural event was met with overwhelming support from all avenues of the bio/pharma industry. On the heels of that outstanding reception, DCAT will return to the picturesque city of Lugano, Switzerland, June 4-5, 2025, for its conference and networking event, Expedition Pharma: Innovation from a PatientFirst Perspective. The diverse and complex nature of the bio/ pharma industry continues to face new challenges from all directions, and there is little doubt that conversations from manufacturing, scientific and technical meetings by staff and operations, up to the Board of Directors and back again, are defining business strategies and tactical programs centered on true innovation, differentiation, adaptability, and long-term profitably to gain a competitive advantage. These are fundamental to survival, let alone growth. As the premier organization for building and maintaining significant networking relationships, DCAT is bringing this conversation to a global audience for those who value vigorous discussions and alternative perspectives and are open to sharing their learning experiences—successes and setbacks. Innovation is the lifeblood of the bio/pharma industry, not only in terms of new product development but also in how the industry adapts its manufacturing and supply-chain operations to respond to a changing marketplace. The question behind all of this is perspective and purpose—is it a patient-first mindset that drives breakthroughs in research, process optimization, quality assurance, and building a robust and resilient supply chain at the core of
RkJQdWJsaXNoZXIy MjY2OTA4MA==